Literature DB >> 18037444

Transition to Community: a program to help clients with schizophrenia move from inpatient to community care; a pilot study.

Leandra Marie Price1.   

Abstract

A pilot study of the Transition to Community program tested the feasibility of conducting a larger trial using the same intervention. An advanced practice psychiatric nurse interviewed hospitalized clients, contacted outpatient clinicians, and communicated with clients after discharge via prepaid cellular phones. Client compliance with medications and outpatient appointments, and the number of hospital readmission days during the 50-day period after discharge were examined. The sample size (N = 13) precluded statistically significant data; however, collective results indicated a probable difference on at least one of the variables. Modifications in methods for a multisite trial, based on this pilot project, are identified in the summary.

Entities:  

Mesh:

Year:  2007        PMID: 18037444     DOI: 10.1016/j.apnu.2006.11.005

Source DB:  PubMed          Journal:  Arch Psychiatr Nurs        ISSN: 0883-9417            Impact factor:   2.218


  3 in total

1.  Risk Factors for Inpatient Psychiatric Readmission: Are There Gender Differences?

Authors:  Katherine Rieke; Corey McGeary; Kendra K Schmid; Shinobu Watanabe-Galloway
Journal:  Community Ment Health J       Date:  2015-08-25

2.  Telephone-delivered psychosocial interventions targeting key health priorities in adults with a psychotic disorder: systematic review.

Authors:  Amanda L Baker; Alyna Turner; Alison Beck; Katherine Berry; Gillian Haddock; Peter J Kelly; Sandra Bucci
Journal:  Psychol Med       Date:  2018-05-25       Impact factor: 7.723

3.  Effectiveness of Transitional Interventions in Improving Patient Outcomes and Service Use After Discharge From Psychiatric Inpatient Care: A Systematic Review and Meta-Analysis.

Authors:  Anna Hegedüs; Bernd Kozel; Dirk Richter; Johann Behrens
Journal:  Front Psychiatry       Date:  2020-01-21       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.